Clinical diagnostics encompasses the detection, diagnosis, and monitoring of diseases and health conditions in patients. Utilizing advanced lab techniques and medical technologies, clinical scientists and healthcare professionals analyze samples such as blood, urine, and tissue to identify biomarkers, pathogens, and other indicators of illness. From point of care testing (POCT) to precision medicine approaches, clinical diagnostics plays a crucial role in early intervention, treatment planning, and disease management. Explore how this field empowers clinicians to deliver accurate diagnoses and improve patient outcomes.
The Human MER Simplex ProcartaPlex kit measures MER protein and is designed to be combinable with other Simplex kits so that you can create your own multiplex panel that utilizes Luminex xMAP technology for protein detection/quantitation.
BioLumix® provides accurate and rapid microbiological answers in a complete system approach using a simple format that offers value.
Automation can improve operations and deliver impressive benefits to your blood center. The Reveos system is an easy-to-use platform that automates and integrates the manual steps of whole blood processing: from start to finish, whole blood to platelet concentrate.
The INTERCEPT Blood System, pathogen reduction system, a proactive approach to TTI risk reduction provides continued protection against TTIs through broad spectrum inactivation of viruses, bacteria, and parasites. INTERCEPT is approved as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD) in platelet components.
The BIOFIRE TORCH is the latest advancement in molecular infectious disease diagnostics, offering scalable configuration, reduced laboratory footprint, customized throughput, and a user-friendly interface.
Heat Aggregated Gamma Globulin acts as a potent classical complement pathway activator, functioning similarly to naturally occurring immune complexes. When activated by a potent activator, such as Quidel’s Complement Activator, nearly all of the C4 in a given complement source may be converted into cleavage products.
For the fast diagnosis of acute myocardial infarction. Troponin is the preferred biomarker in defining AMI according to the European Society of Cardiology (ESC) guidelines.5 In addition, it is the gold standard to distinguish between AMI and non-AMI patients. Roche Troponin T-high sensitive (TnT-hs) can reduce the time needed to rule-in or rule-out NSTEMI to as little as just 1 hour.
